People in the project

People in the Nanomedicine research group at the department of Clinical Science.

  • Principle Investigator: Professor Lars Herfindal (PhD).
  • Researcher Reidun Æsøy (PhD). Precision therapy in childhood cancer.
  • PhD student Edvin Tang Gundersen (MSc). Repurposing of drugs by nanoencapsulation.
  • PhD student Jan-Lukas Førde. Zebrafish larvae as a model for myeloid malignancies.
  • Master student (Nanomedicine) Rannveig Våg. Nanoencapsulation of AML drugs
  • Master student (pharmacy) Anette Sivertsen. Zebrafish larvae to study biotransformation of drugs
  • Master student (pharmacy) Anja Strandvoll Dyrdal

Previous group members:

  • PhD student Ronja Bjørnstad (MSc). Nanoformulations for improved anti-cancer therapy.
  • Master student (pharmacy) Tuva Torblå Bakke. Liposomes to treat AML
  • Master student (pharmacy) Bendik Auran Rathe. Compounds from plants with anti-AML activity.
  • Master student (pharmacy) Viola Lekve. Iodinin as a new agent for AML therapy
  • Master student Kaja Skålnes Knudsen (Masterprogram in Nanoscience). Multifunctional liposomes to reduce cytostatic-induced cardiotoxicity.
  • Master student (pharmacy) Anne Oldeide Hay. Electro-Membrane Extraction (EME) of anti-cancer drugs.
  • Master student (pharmacy) Noah Erchinger. Novel compounds for treatment of myeloid malignancies.
  • Master student (pharmacy) Luwam Ghebrihiwet Weldeab. Compounds from plants with anti-AML activity.

Collaborators at the University of Bergen:

  • Prof. Aurora Martinez and Maite Bezem (PhD student). Nano-particle mediated delivery of enzymes in the brain.
  • Dr. Astrid Olsnes Kittang. Improved therapy of high-risk myelodysplastic syndrome.
  • Profs. Håkon Reikvam, Bjørn-Tore Gjertsen, Øystein Bruserud. Drug development for acute myeloid leukaemia.
  • Prof. Torgils Fossen. Anti-cancer compounds from plants.

Collaborators in Norway:

  • Prof. Gareth Griffiths. University of Oslo. Test of nano-particle efficacy using a zebrafish cancer model.
  • Prof. Pål Rongved. University of Oslo. Chemical synthesis of natural compounds for nanonization.

International collaboration:

  •  Dr. Gillian Barratt, Institut Galién, Universisty of Paris-sud. Development of nano-carriers for anti-cancer drugs.
  • Prof. Kaarina Sivonen, University of Helsinki, Finland. Bioactive compounds from cyanobacteria.



Leave a Reply

Your email address will not be published. Required fields are marked *